Levaquin Lawsuit,

January 12th, 2009

Levaquin (levofloxacin) is a fluroquinolone antibiotic used to treat
bacterial infections (such as skin infection, respiratory tract, sinus, urinary tract infection, pneumonia, chronic bronchitis, and kidney infection). Levaquin is manufactured by Ortho-McNeil Pharmaceuticals, and was approved by the FDA in 1997. Levaquin is only availab…

Nurse Practitioner - Therapy for Multi-Drug Resistant Strep in CAP

January 11th, 2009

Levofloxacin (Levaquin) is now approved by the FDA to treat multidrug-resistant strains of Streptococcus pneumoniae in community-acquired pneumonia (CAP), in the forms of tablets, injection, and in 5% dextrose (Levaquin Injection). Levofloxacin is a product of Johnson & Johnson….

Family Pratice News - Levaquin Can Be Used for Complex Skin Infections - Brief Article

January 8th, 2009

The Food and Drug Administration has expanded the indications for Levaquin to include complicated skin and skin structure infections, such as major abscesses; ulcers; and infections of deep.wounds due to surgical incisions, bites, or lacerations.
Since 199…

Buy Levaquin from Best Offshore Online Pharmacy

January 5th, 2009

The Levaquin Antibiotic

Levaquin is the brand name for
one of the antibiotics in the family of drugs called fluoroquinolones.
Fluoroquinolones, which also includes brand na…

Journal of Drugs in Dermatology - Generic 750 mg levofloxacin for bacterial infections in adults

January 1st, 2009

A first-time generic formulation of 750 mg levofloxacin tablets (Levaquin, Ortho-McNeil Pharmaceuticals, Inc.) has been approved by the FDA. Levofloxacin is a fluoroquinolone antibiotic and is currently indicated for various infections in adults including uncomplicated skin and skin structure infections.

Related Results

Levaquin approvalLevaquin…

Drug Store News - Ortho-McNeil

December 27th, 2008

The FDA last month approved a new five-day 750 mg once-daffy regimen of Ortho-McNeil’s Levaquin (levofloxacin) to treat acute bacterial sinusitis.
The newly approved regimen is as effective as a 10-day course of Levaquin 500 mg. Levaquin generated $1.3 billion in sales in 2004.

Related Results

Levaquin a…

Adverse Event Reporting News - Levaquin tablets and oral solution

December 24th, 2008

Levaquin (levofloxacin) Injection, for Intravenous Use
Levaquin (levofloxacin in 5% dextrose) Injection, for Intravenous Use
WARNINGS AND PRECAUTIONS
Photosensitivity/Phototoxicity
Moderate to severe photosensitivity/phototoxicity reactions, the latter of which may manifest as exaggerated sunburn reactions (e.g., burni…

Internal Medicine News - Oral solution levaquin approved

December 20th, 2008

Levaquin (levofloxacin) oral solution 25 mg/mL is indicated for the treatment of acute maxillary sinusitis, acute bacterial exacerbation of chronic bronchitis, nosocomial pneumonia, community-acquired pneumonia, complicated and uncomplicated skin infections, chronic bacterial prostatitis, complicated and uncomplicated urinary tract infections, and acute pyelonephritis.

Related Results

Levaquin approvalLevaquin doseNew indication for LevaquinLeva…

Ear, Nose & Throat Journal - The prevalence of colonization with drug-resistant pneumococci among adult workers in children’s daycare

December 14th, 2008

The article “Medications for Migraine Prophylaxis” (January 1, 2006, page 72) contained an error in the section titled “Pregnancy” on page 77. The second sentence of this section incorrectly listed fluoxetine (Prozac) as a U.S. Food and Drug Administration (FDA) pregnancy category B drug, and that it could be considered for preventive therapy of chronic migraine in wom…

LegalView Informs Mesothelioma Blog Readers with Details on Asbestos: Silent Killer of American Vete

December 7th, 2008

Denver, CO - LegalView, the most comprehensive legal resource available on the Internet, unveiled details of a “silent killer” of American veterans that dates back to World War II. Asbestos fibers and dust may have been silently killing veterans returning home from American-fought wars, and has long been overlooked, according to veteran and book author William S. Burton Sr. Currently, many scientists and…